Education
About Us
Working with TipRanks
Follow Us
Seer (SEER)
NASDAQ:SEER
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.37Last Year’s EPS
-0.35Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 13, 2025
|% Change Since: 8.33%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted robust revenue growth and significant achievements, including securing a major contract for a large-scale study and expanding partnerships. However, these positives were tempered by ongoing macroeconomic challenges, pressure on budgets, and uncertainty in government funding. Despite these concerns, Seer remains optimistic about its growth prospects.Company Guidance
During Seer's first quarter 2025 earnings call, the company reiterated its full-year revenue guidance of $17 to $18 million, anticipating 24% year-over-year growth at the midpoint. The company reported a strong start to the year with $4.2 million in revenue for the first quarter, a 37% increase compared to the previous year, driven by high demand for the Proteograph product suite. Gross profit reached $2.1 million, with a gross margin of 49%, up from 44% in the same quarter of 2024. Operating expenses decreased by 14% to $22.8 million. Despite macroeconomic pressures, including tariff implications and funding uncertainties, Seer maintains a robust balance sheet with approximately $285 million in cash, cash equivalents, and investments, allowing them to continue strategic investments in R&D and share repurchase programs. The company expects free cash flow loss to be between $40 million and $45 million for the year, while managing to repurchase 352,000 Class A shares in the first quarter.Strong Start to 2025 with Revenue Growth
Seer delivered $4.2 million in revenue for the first quarter of 2025, marking a 37% increase compared to $3.1 million in the first quarter of 2024.
Significant Contract Secured for Large-Scale Study
Discovery Life Sciences, in collaboration with Seer, secured a contract for a 10,000-sample study using the Proteograph product suite, marking a milestone for the proteomics market.
High Customer Engagement with STAC
Half of the instrument shipments in Q1 were from customers who had previously accessed STAC, representing the highest number of STAC-to-instrument conversions in a single quarter.
Partnership with Thermo Fisher Scientific
Expanded partnership to co-market and sell the Proteograph product suite alongside Orbitrap Astral mass spectrometer, enhancing commercial reach.
Reduced Operating Expenses
Total operating expenses decreased by 14% to $22.8 million in Q1 2025 compared to $26.6 million in Q1 2024, driven by decreases in stock-based compensation and laboratory expenses.
SEER Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SEER Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 13, 2025 | $1.92 | $2.11 | +9.90% |
Feb 27, 2025 | $2.20 | $2.10 | -4.55% |
Nov 06, 2024 | $2.07 | $2.22 | +7.25% |
Aug 08, 2024 | $1.73 | $1.72 | -0.58% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Seer (SEER) report earnings?
Seer (SEER) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is Seer (SEER) earnings time?
Seer (SEER) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SEER EPS forecast?
SEER EPS forecast for the fiscal quarter 2025 (Q2) is -0.37.